The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

August 17, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers BandraKurla Complex, Dalal Street, Bandra (E), Mumbai - 400051 Mumbai- 400001 (SYMBOL: THYROCARE) (SCRIP CODE: 539871) Sub: Communication received from Docon Technologies Private Limited (‘Promoter’) regarding release of pledge over 7,94,69,696 Equity Shares of Thyrocare Technologies Limited (“Company”) Ref: Disclosure pursuant to Regulations 29(2), 31(2) and 31(3) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as received from the Promoter Dear Sir/Madam, We wish to inform you that the Company has received a communication from Docon Technologies Private Limited, Promoter of the Company, inter alia informing that pursuant to the full redemption and repayment of the Non-Convertible Debentures issued by API Holdings Limited, the ultimate holding company of the Company, the pledge created over 7,94,69,696 equity shares of the Company held by the Promoter has been released. The Promoter has further informed that, following the aforesaid repayment, API Holdings Limited has no outstanding debt under the said Non-Convertible Debentures and the entire shareholding held by the Promoter in the Company is now free from pledge. In this regard the Promoter has submitted the requisite disclosures pursuant to Regulations 29(2), 31(2) and 31(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. A copy of the disclosure received from the Promoter is enclosed herewith for your information and taking the same on record. Yours Faithfully, For Thyrocare Technologies Limited, Brijesh Kumar Company Secretary and Compliance Officer Encl. A/a